Mallinckrodt plc announces that the Irish High Court has given the necessary ruling to enable its combination with Endo, Inc. (OTCQX: NDOI), advancing the companies’ plan to merge in a stock and cash transaction that will create a global, scaled, diversified therapeutics leader. The Court’s ruling is the final substantive legal step required for the transaction and follows a vote by each company’s shareholders last month to approve the merger. With these approvals in hand, Mallinckrodt and Endo expect to complete their combination in early August, pending the satisfaction of the remaining closing steps. Mallinckrodt’s headquarters in Dublin, Ireland, will serve as the combined company’s global headquarters.
Read the full article: Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc. //
Source: https://www.prnewswire.com/news-releases/mallinckrodt-receives-necessary-ruling-from-irish-high-court-to-combine-with-endo-inc-302507886.html